Scientists may have found a way to kill cancer cells without chemotherapy

Chemo is our best response to cancer so far. A novel new therapy could render it obsolete.

  • Researchers at Northwestern have discovered a genetic "kill code" that might enable the destruction of cancer cells.
  • This novel new therapy "downstream" of chemo might destroy cancer cells without affecting the body's immune system.
  • While no animal trials have been conducted, this potential therapy could signal the demise of chemotherapy.

One of the biggest criticisms about our current approach to treating cancer is chemotherapy. Critics liken it to dropping a bomb on a village instead of singling out homes of bad actors. War metaphors are impossible to avoid when discussing cancer, for good reason: It is an all-out assault on your body.

When I went through testicular cancer, I was given three options: Since it had not metastasized, do nothing after surgery and monitor; two weeks of radiation therapy (which often leads to another cancer down the road); one round of chemotherapy, mostly as a preventive measure. I chose the latter.

Even my oncologist knew it wasn't an ideal solution. As with much of medicine, you go with what's best until something better is discovered. Chemotherapy is an umbrella term with numerous dosages and drugs in the various courses. My one round was on the mild side; a close friend had 12 rounds in four months while battling a much more aggressive intestinal cancer. His immune system needed serious rebuilding after that incident.

While there are many applications and complications associated with chemotherapy, the commonly understood mechanism is the paralyzing of bone marrow, which leads to lower amounts of red and white blood cells and platelets. This results in the depression of your immune system. Along with the suppression and cessation of growth of cancer cells, numerous important cells are also damaged, stressed, or destroyed. In very aggressive cancers, bone marrow stem cells are obliterated and must be replaced.

Making cancer as harmless as the common cold | Michio Kaku

For most people, it's time and healing. Destroy your immune system, rest, eat well, and exercise to the degree you can to keep blood flowing. While not ideal, it works for many. Billions of dollars are spent each year searching for better means of fighting this disease. A new course of action shows promise that one day, chemotherapy too might be a practice of the past.

Published in the journal Nature Communications, researchers at Northwestern University have discovered a genetic "kill code" that could enable the destruction of cancer cells without the "spray and pray" mentality of chemotherapy.

The hardest part of cancer research thus far has been finding a way to destroy cancer cells without affecting the rest of the body's networks. In 2017, a team led by Marcus E Peter, a professor at Northwestern's Feinberg School of Medicine, discovered that every cell in our body has a unique code that can trigger cell death. His team did not understand how to switch that code on, however.

Bringing us to the current study, also led by Peter. As Lisa Schönhaar and Ruqayyah Moynihan write for Business Insider:

According to the new study, the code is available as information in ribonucleic acid, or RNA, and microRNAs. The small RNA molecules can effectively kill cancer cells, a process that chemotherapy is meant to activate.

Photo: Anne-Christine Poujoulat/AFP/Getty Images

Testing this method on four cell lines, two human and two mouse, the team identified over 700 targets leading to cancer cell proliferation. They found that chemotherapy drugs kill cancer cells in part by triggering the release of a toxic mechanism, resulting in the release of tumor-suppressive miRNAs. By targeting this specific mechanism, they believe they might be able to trigger this action without the complications posed by current genotoxic drugs.

As Peter commented on the study:

"Now that we know the kill code, we can trigger the mechanism without having to use chemotherapy and without messing with the genome… My goal was not to come up with a new artificial toxic substance. I wanted to follow nature's lead. I want to utilize a mechanism that nature developed."

Unfortunately, such an application is years away. The team has yet to conduct a single animal trial. That said, Peter hopes to turn this knowledge into a "novel form of therapy." One major problem with chemotherapy, Peter says, is that since it triggers the release of toxic RNAs, secondary cancers can result as a consequence. The new potential therapy his team is developing is "downstream" of chemo and may avoid the side effects of destroying an entire immune system.

As with all breakthrough drugs, numerous studies will have to be conducted. But the time spent might be worth it, if this kill code can be put into action.

--

Stay in touch with Derek on Twitter and Facebook.

Befriend your ideological opposite. It’s fun.

Step inside the unlikely friendship of a former ACLU president and an ultra-conservative Supreme Court Justice.

Sponsored by Charles Koch Foundation
  • Former president of the ACLU Nadine Strossen and Supreme Court Justice Antonin Scalia were unlikely friends. They debated each other at events all over the world, and because of that developed a deep and rewarding friendship – despite their immense differences.
  • Scalia, a famous conservative, was invited to circles that were not his "home territory", such as the ACLU, to debate his views. Here, Strossen expresses her gratitude and respect for his commitment to the exchange of ideas.
  • "It's really sad that people seem to think that if you disagree with somebody on some issues you can't be mutually respectful, you can't enjoy each other's company, you can't learn from each other and grow in yourself," says Strossen.
  • The opinions expressed in this video do not necessarily reflect the views of the Charles Koch Foundation, which encourages the expression of diverse viewpoints within a culture of civil discourse and mutual respect.
Keep reading Show less

3 ways to find a meaningful job, or find purpose in the job you already have

Learn how to redesign your job for maximum reward.

Videos
  • Broaching the question "What is my purpose?" is daunting – it's a grandiose idea, but research can make it a little more approachable if work is where you find your meaning. It turns out you can redesign your job to have maximum purpose.
  • There are 3 ways people find meaning at work, what Aaron Hurst calls the three elevations of impact. About a third of the population finds meaning at an individual level, from seeing the direct impact of their work on other people. Another third of people find their purpose at an organizational level. And the last third of people find meaning at a social level.
  • "What's interesting about these three elevations of impact is they enable us to find meaning in any job if we approach it the right way. And it shows how accessible purpose can be when we take responsibility for it in our work," says Hurst.
Keep reading Show less

Physicist advances a radical theory of gravity

Erik Verlinde has been compared to Einstein for completely rethinking the nature of gravity.

Photo by Willeke Duijvekam
Surprising Science
  • The Dutch physicist Erik Verlinde's hypothesis describes gravity as an "emergent" force not fundamental.
  • The scientist thinks his ideas describe the universe better than existing models, without resorting to "dark matter".
  • While some question his previous papers, Verlinde is reworking his ideas as a full-fledged theory.
Keep reading Show less

UPS has been discreetly using self-driving trucks to deliver cargo

TuSimple, an autonomous trucking company, has also engaged in test programs with the United States Postal Service and Amazon.


PAUL RATJE / Contributor
Technology & Innovation
  • This week, UPS announced that it's working with autonomous trucking startup TuSimple on a pilot project to deliver cargo in Arizona using self-driving trucks.
  • UPS has also acquired a minority stake in TuSimple.
  • TuSimple hopes its trucks will be fully autonomous — without a human driver — by late 2020, though regulatory questions remain.
Keep reading Show less